tradingkey.logo

Thermo Fisher Scientific Inc

TMO
View Detailed Chart
567.320USD
+11.100+2.00%
Close 10/31, 16:00ETQuotes delayed by 15 min
214.23BMarket Cap
32.61P/E TTM

Thermo Fisher Scientific Inc

567.320
+11.100+2.00%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.00%

5 Days

-0.80%

1 Month

+16.97%

6 Months

+32.24%

Year to Date

+9.05%

1 Year

+3.03%

View Detailed Chart

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Thermo Fisher Scientific Inc's Score

Industry at a Glance

Industry Ranking
11 / 210
Overall Ranking
56 / 4621
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 27 analysts
Buy
Current Rating
610.670
Target Price
+9.38%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Thermo Fisher Scientific Inc Highlights

StrengthsRisks
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 9.41%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 9.41%.
Fairly Valued
The company’s latest PE is 32.10, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 345.55M shares, decreasing 2.20% quarter-over-quarter.
Held by Wallace Weitz
Star Investor Wallace Weitz holds 150.45K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.04.

Financial Indicators

EPS

No Data

Total revenue

No Data

Thermo Fisher Scientific Inc Info

Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
Ticker SymbolTMO
CompanyThermo Fisher Scientific Inc
CEOMr. Marc N. Casper
Websitehttps://www.thermofisher.com/
KeyAI